CDK2AP1 and hepatocellular carcinoma: In order to explore the therapeutic potential of CDK2AP1 in HCC immunotherapy, correlation analysis was conducted, which found that the correlation between CDK2AP1 and neoantigens, MSI, TMB is weak.